List of insiders holdings for CNS Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Climaco John M Chief Executive Officer | 2024-04-10 21:50:50 | 1,036,066 0 | 1,036,066 | Form 4 |
| Cortice Biosciences Inc. 10% Owner | 2024-08-06 17:11:50 | 573,368 0 | 573,368 | Form 4 |
| Gumulka Jerzy Director | 2024-04-10 21:52:22 | 277,188 0 | 277,188 | Form 4 |
| Evans Carl Anthony Director | 2024-04-10 21:52:02 | 276,688 0 | 276,688 | Form 4 |
| Priebe Waldemar 10% Owner | 2023-08-01 17:10:16 | 0 156,807 | 156,807 | Form 4 |
| Keyes Jeffry R. Director | 2024-04-10 21:52:52 | 143,356 0 | 143,356 | Form 4 |
| Charles Faith L. Director | 2024-04-10 21:50:26 | 112,130 0 | 112,130 | Form 4 |
| Cockroft Bettina M. Director | 2024-04-10 21:51:15 | 88,648 0 | 88,648 | Form 4 |
| Mahery Amy Director | 2024-04-10 21:53:15 | 77,340 0 | 77,340 | Form 4 |
| Andraczke Andrzej Director | 2023-10-12 18:00:06 | 45,428 0 | 45,428 | Form 4/A |
| Downs Christopher Chief Financial Officer | 2024-04-10 21:51:35 | 443.14 0 | 443.14 | Form 4 |